SCHEMBL23299479

SCHEMBL23299479

Clc1cc(Cl)c2oc3cc(Br)ccc3c2c1

nearest known ligand 0.61

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 19/20 0.61
▸ PIM1 P11309 1/20 0.37
▸ CSNK2A2 P19784 1/20 0.37
▸ CSNK2B P67870 1/20 0.37
▸ PIM3 Q86V86 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30930040 1.00 AHR (0.61) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL19661827 0.87 AHR (0.50) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL23299464 0.86 AHR (0.61) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL28569376 0.84 AHR (0.67) AHR
SCHEMBL22117396 0.79 AHR (0.51) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL29976750 0.79 AHR (0.51) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL23564153 0.79 AHR (0.61) AHR
SCHEMBL23764967 0.79 AHR (0.38) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL20739897 0.77 AHR (0.62) AHR
SCHEMBL28567689 0.76 AHR (0.57) AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-31 — — US disclosed
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-31 — — US disclosed
US-20220306616-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-09-29 — — US disclosed
EP-4019513-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME LG Chem, Ltd. (KR) 2022-06-29 — — EP disclosed
WO-2021125552-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2021-06-24 — — WO disclosed
WO-2021125552-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2021-06-24 — — WO disclosed
EP-3415512-B1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG CHEMICAL LTD (KR) 2021-04-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CRY2, PPOX AHR 20/4885PIM1 1125/4885CSNK2A2 2320/4885
US-20220306616-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME C1S, CRY1, C5 AHR 20/4885PIM1 4239/4885CSNK2A2 1792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback